Mangoceuticals Inc. (MGRX)
NASDAQ: MGRX
· Real-Time Price · USD
1.61
-0.05 (-3.01%)
At close: May 01, 2025, 3:39 PM
-3.01% (1D)
Bid | 1.61 |
Market Cap | 10.09M |
Revenue (ttm) | 615.87K |
Net Income (ttm) | -8.71M |
EPS (ttm) | -4.84 |
PE Ratio (ttm) | -0.33 |
Forward PE | n/a |
Analyst | n/a |
Ask | 1.64 |
Volume | 79,249 |
Avg. Volume (20D) | 281,632 |
Open | 1.66 |
Previous Close | 1.66 |
Day's Range | 1.60 - 1.69 |
52-Week Range | 1.49 - 16.80 |
Beta | 2.42 |
About MGRX
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc....
Sector Healthcare
IPO Date Mar 21, 2023
Employees 3
Stock Exchange NASDAQ
Ticker Symbol MGRX
Website https://www.mangorx.com
6 days ago
-13.81%
MGRX stock has given up its prior gain. Mangoceuti...
Unlock content with
Pro Subscription
6 days ago
-13.81%
Mangoceuticals shares are trading higher after the company entered an Intellectual Property Purchase Agreement for IP and assets of Smokeless Technology Corp.

1 week ago · accessnewswire.com
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health LandscapeDALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when ...